GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN

Jianbo Qing1,2, Lijuan Zhang1, Ru Fan1

  • 1Department of Nephrology, Shanxi Provincial People's Hospital (Fifth Hospital), Shanxi Medical University, Taiyuan, 030001, China.

Scientific Reports
|January 31, 2025
PubMed

Insights

Oxidative stress contributes to kidney disease progression in IgA nephropathy (IgAN). This study reveals enhanced ferroptosis suppression in proximal tubule cells, with GPX4 as a key marker and therapeutic target to mitigate kidney injury.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Oxidative stress (OS) is a key mechanism in renal injury, fibrosis, and failure.
  • Its specific role in IgA nephropathy (IgAN), a primary cause of chronic kidney disease, is not fully understood.
  • Investigating OS mechanisms in IgAN is crucial for understanding kidney disease progression.

Purpose of the Study:

  • To investigate the effects of oxidative stress in IgA nephropathy.
  • To identify mechanisms of cell and tissue injury and protection in IgAN.
  • To explore the role of ferroptosis in IgAN pathogenesis.

Main Methods:

  • Analysis of single-cell RNA sequencing (scRNA-seq) and microarray data from IgAN patients.
  • Gene Set Variation Analysis (GSVA) to assess pathway activity.
  • Enrichment analysis and immunohistochemistry to identify key regulators like GPX4.

Main Results:

  • Significant alterations in OS pathways were found in proximal tubule cells (PTCs) of IgAN patients.
  • Differentially expressed genes linked OS to ferroptosis, with enhanced ferroptosis suppression in IgAN PTCs.
  • GPX4 expression was significantly altered in IgAN PTCs and validated in patient kidney tissues.
  • Ferroptosis activity in the tubulointerstitium showed decreased driving and suppression, with stronger overall inhibition.

Conclusions:

  • Ferroptosis inhibition may alleviate oxidative stress injury in IgA nephropathy.
  • GPX4 is a significant marker for PTCs in IgAN.
  • GPX4 represents a potential therapeutic target to slow IgAN progression.